Treatment Strategies in Primary Vitreoretinal Lymphoma A 17-Center European Collaborative Study

Riemens, Anjo; BROMBERG, Jacoline; TOUITOU, Valerie; SOBOLEWSKA, Bianka; MISSOTTEN, Tom; BAARSMA, Seerp; HOYNG, Carel; CORDERO-COMA, Miguel; Tomkins-Netzer, Oren; ROZALSKI, Anna; Tugal-Tutkun, Nuriye; Guex-Crosier, Yan; LOS, Leonoor; BOLLEMEIJER, Jan; NOLAN, Andrew; PAWADE, Joya; Willermain, Francois; BODAGHI, Bahram; ten Dam-van Loon, Ninette; DICK, Andrew; ZIERHUT, Manfred; Lightman, Susan; MACKENSEN, Friederike; Moulin, Alexandre; Erckens, Roel; WENSING, Barbara; LE HOANG, Phuc; Lokhorst, Henk; ROTHOVA, Aniki

doi:10.1001/jamaophthalmol.2014.4755

Treatment Strategies in Primary Vitreoretinal Lymphoma A 17-Center European Collaborative Study

Atıf İçin Kopyala

Riemens A., BROMBERG J., TOUITOU V., SOBOLEWSKA B., MISSOTTEN T., BAARSMA S., ...Daha Fazla

JAMA OPHTHALMOLOGY, cilt.133, sa.2, ss.191-197, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 133 Sayı: 2
Basım Tarihi: 2015
Doi Numarası: 10.1001/jamaophthalmol.2014.4755
Dergi Adı: JAMA OPHTHALMOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.191-197
İstanbul Üniversitesi Adresli: Evet

Özet

IMPORTANCE The best treatment option for primary vitreoretinal lymphoma (PVRL) without signs of central nervous system lymphoma (CNSL) involvement determined on magnetic resonance imaging or in cerebrospinal fluid is unknown.